Download (pdf, 174 KB)

This information leaflet aims to answer common questions you may have if you have been prescribed adalimumab (also known as 'Humira') to treat your Crohn’s Disease or Ulcerative Colitis, the two main forms of Inflammatory Bowel Disease (IBD). It is not intended to replace specific advice from your own doctor or any other health professional.